A Model for Managing Crime Scene Examiners

Police forces in the UK employ specially trained Crime Scene Examiners (CSEs) to provide forensic science support to the investigation of crime. Previous research (Bradbury and Feist 2005; Williams 2004) has shown wide variations in the management, deployment, and performance of this staff group and, as such, there is a need to develop performance indicators as a measure of effectiveness. This paper looks at the performance and management of CSEs in Durham Constabulary and discusses a model which focuses on the quality of the work of CSEs rather than the quantity of scenes visited, fingermarks lifted or DNA samples collected. Durham Constabulary focus on three main areas of performance to manage their crime scene examiners: level of activity, quality of materials collected, and the conversion of forensic materials into intelligence matches. In this paper we explore a model of performance management which demonstrates how activity measures and review processes can be implemented and utilised to provide insight into the effectiveness of forensic science. Performance management data collected from 24 CSEs over a one-year period (January to December 2011) is used to discuss the role of forensic performance measures in a scientific support unit, reflecting on the strengths and weaknesses of the measures collected

Crime scene examiners and volume crime investigations: an empirical study of perception and practice

Most police forces in the UK employ specially trained crime scene examiners (CSEs) to provide forensic science support to the investigation of crime. Previous research has shown wide variations in the management, deployment, and performance of this staff group. There is also evidence that informal elements of professional and organisational culture, in particular the role characterisations of crime scene examiners, also have a bearing on their effective use in the investigation of high volume property crime. These issues are explored as part of a more extensive study of forensic science provision in the two largest police forces in Scotland and by the four main Scottish Police Services Authority Forensic Services (SPSA FS) units. A range of staff in these organisations described their understandings of the role of crime scene examiners – as evidence collectors, forensic investigators, specialist advisers, or any combination of these. Whilst two thirds (62%) of respondents recognised the complexity and scope of the role of CSEs including its cognitive elements, a substantial minority (38%) categorised the role as having a single element – collecting evidence – and therefore perceived it as limited largely mechanical in character. The reasons for, and consequences of, this perception are considered, and the paper concludes with a challenge to reconsider this limited view of what crime scene examiners can contribute to volume crime investigations

An investigation into the dynamics of lip-prints as a means of identification

Individualisation and identification by analysing the lines and furrows contained within lip patterns has been broadly discussed in the literature; however, due to a lack of research the reliability of this technique as evidence is questioned. Research was undertaken to test the classification system of lip print patterns and features that had previously been established, and it aimed to determine a method for cataloguing lip prints to include lip pattern typing and the comparison of pattern imperfections. Two sets of lip prints (eight impressions in total) were collected from 36 volunteers (25 females, 11 males). Volunteers were recruited at Teesside University and the University of Edinburgh. The ages of volunteers ranged from 21–60 years. The research found that lip patterns could be divided into five types, each type increasing in furrow complexity. Characteristic details from the lip prints were annotated based on the classification terminology used in fingerprint analysis (e.g. bifurcation) as well as classification systems used by other researchers previously. Lip print impressions were compared with known and unknown individuals as well as photographs, and the results demonstrated that it was possible to establish whether an impression could be linked to the source

PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita

Pemphigoid diseases such as epidermolysis bullosa acquisita (EBA) may be difficult to treat. In pemphigoid diseases, mucocutaneous blistering is caused by autoantibodies to hemidesmosomal antigens; in EBA the autoantigen is type VII collagen. Despite growing insights into pemphigoid disease pathogenesis, corticosteroids are still a mainstay of treatment. In experimental EBA, myeloid cell activation is a key event leading to blistering. Activation of these cells depends on phosphodiesterase (PDE) 4. We therefore evaluated the potential for PDE4 inhibition in EBA: PDE4 was highly expressed in inflammatory cells and in the epidermis of patients compared with healthy skin samples. PDE4 inhibitors rolipram, roflumilast, and roflumilast N-oxide prevented the release of immune complex-induced reactive oxygen species from polymorphonuclear leukocytes and separation of the dermal-epidermal junction of skin incubated with antibodies to collagen type VII and polymorphonuclear leukocytes. The PDE4 inhibitors also impaired CD62L shedding and decreased CD11b expression on immune complex-stimulated polymorphonuclear leukocytes. For in vivo validation, experimental EBA was induced in mice by transfer of anti-collagen type VII IgG or immunization with collagen type VII. Roflumilast dose-dependently reduced blistering in antibody transfer-induced EBA and also hindered disease progression in immunization-induced EBA. PDE4 inhibition emerges as a new treatment modality for EBA and possibly other neutrophil-driven pemphigoid diseases.</p

Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita

Epidermolysis bullosa acquisita (EBA) is a rare, but prototypical, organ-specific autoimmune disease, characterized and caused by autoantibodies against type VII collagen (COL7). Mucocutaneous inflammation, blistering, and scarring are the clinical hallmarks of the disease. Treatment of EBA is difficult and mainly relies on general immunosuppression. Hence, novel treatment options are urgently needed. The phosphatidylinositol-3-kinase (PI3K) pathway is a putative target for the treatment of inflammatory diseases, including EBA. We recently discovered LAS191954, an orally available, selective PI3Kδ inhibitor. PI3Kδ has been shown to be involved in B cell and neutrophil cellular functions. Both cell types critically contribute to EBA pathogenesis, rendering LAS191954 a potential drug candidate for EBA treatment. We, here, demonstrate that LAS191954, when administered chronically, dose-dependently improved the clinical phenotype of mice harboring widespread skin lesions secondary to immunization-induced EBA. Direct comparison with high-dose corticosteroid treatment indicated superiority of LAS191954. Interestingly, levels of circulating autoantibodies were unaltered in all groups, indicating a mode of action independent of the inhibition of B cell function. In line with this, LAS191954 also hindered disease progression in antibody transfer-induced EBA, where disease develops dependent on myeloid, but independent of B cells. We further show that, in vitro, LAS191954 dose-dependently impaired activation of human myeloid cells by relevant disease stimuli. Specifically, immune complex-mediated and C5a-mediated ROS release were inhibited in a PI3Kδ-dependent manner. Accordingly, LAS191954 also modulated the dermal–epidermal separation induced in vitro by co-incubation of immune complexes with polymorph nuclear cells, thus pointing to an important role of PI3Kδ in EBA effector functions. Altogether, these results suggest a new potential mechanism for the treatment of EBA and potentially also other autoimmune bullous diseases

Intelligente Vernetzung zur autonomen Fräsbearbeitung von Strukturbauteilen - Ergebnisbericht des BMBF Verbundprojektes TensorMill

Digitalisierte Prozesse können zukünftig zu einer intelligenten Fertigung beitragen, um den Herausforderungen einer intelligent vernetzten, autonomen Fertigung von sicherheitsrelevanten Integralbauteilen zu begegnen. Die Herausforderungen hierbei liegen insbesondere in der Aufzeichnung und Extraktion von nutzerrelevanten Daten zur Steigerung der Produktivität bei der Fertigung von sicherheitsrelevanten Integralbauteilen für die Luft- und Raumfahrtbranche. An diesem Punkt hat das Verbundforschungsprojekt „TensorMill“ angesetzt. Ziel des Projekts war es, die Produktivität in der spanenden Fertigung sicherheitsrelevanter Integralbauteile durch die Entwicklung und den Aufbau einer intelligent, vernetzten, autonomen Fertigung zu erhöhen und die Prozesssicherheit zu verbessern. Die intelligente Fertigung soll dabei in der Lage sein, auf möglichst viele Situationen im Fertigungsprozess mit Hilfe von künstlicher Intelligenz (KI) zu reagieren. Für die Implementierung der KI-basierten Lösungen sind im Projekt fortschrittliche Methoden und Vorgehensweisen entstanden, welche es ermöglichen, die Daten von Produktionsmitteln in einer einfachen Form nutzbar zu machen, damit diese einen Mehrwert für Hersteller und Anwender bringen. Die aufbereiteten Daten dienten schließlich der Umsetzung von KI-basierten Lösungen zur prozessparallelen Qualitätsprognose und Werkzeugzustandserkennung. Darüber hinaus wurde ein entwickeltes cyber-physisches Spannsystem entwickelt, um neuartige Ansätze zur Abdrängungskompensation und Echtzeitbewertung der Prozessstabilität zu erforschen

Reduced Skin Blistering in Experimental Epidermolysis Bullosa Acquisita After Anti-TNF Treatment

Epidermolysis bullosa acquisita (EBA) is a difficult-to-treat subepidermal autoimmune blistering skin disease (AIBD) with circulating and tissue-bound anti-type VII collagen antibodies. Different reports have indicated increased concentration of tumor necrosis factor a (TNF) in the serum and blister fluid of patients with subepidermal AIBD. Furthermore, successful anti-TNF treatment has been reported for individual patients with AIBD. Here we show that in mice, induction of experimental EBA by repeated injections of rabbit anti-mouse type VII collagen antibodies led to increased expression of TNF in skin, as determined by real-time polymerase chain reaction (PCR) and immunohistochemistry. To investigate whether the increased TNF expression is of functional relevance in experimental EBA, we inhibited TNF function using the soluble TNF receptor fusion protein etanercept (Enbrel) or a monoclonal antibody to murine TNF. Interestingly, mice that received either of these treatments showed significantly milder disease progression than controls. In addition, immunohistochemical staining demonstrated reduced numbers of macrophages in lesional skin in mice treated with TNF inhibitors compared with controls. Furthermore, etanercept treatment significantly reduced disease progression in immunization-induced EBA. In conclusion, increased expression of TNF in experimental EBA is of functional relevance, as both the prophylactic blockade of TNF and the therapeutic use of etanercept impaired induction and progression of experimental EBA. Thus, TNF is likely to serve as a new therapeutic target for EBA and AIBDs with a similar pathogenesis

Hypopituitarism is associated with lower oxytocin concentrations and reduced empathic ability

Purpose Central diabetes insipidus is characterised by arginine vasopressin deficiency. Oxytocin is structurally related to vasopressin and is synthesised in the same hypothalamic nuclei, thus we hypothesised that patients with acquired central diabetes insipidus and anterior hypopituitarism would display an oxytocin deficiency. Moreover, psychological research has demonstrated that oxytocin influences social and emotional behaviours, particularly empathic behaviour. We therefore further hypothesised that central diabetes insipidus patients would perform worse on empathy-related tasks, compared to age-matched and gender-matched clinical control (clinical control-isolated anterior hypopituitarism) and healthy control groups. Method Fifty-six participants (age 46.54 ± 16.30 yrs; central diabetes insipidus: n = 20, 8 males; clinical control: n = 15, 6 males; healthy control: n = 20, 7 males) provided two saliva samples which were analysed for oxytocin and completed two empathy tasks. Results Hypopituitary patients (both central diabetes insipidus and clinical control groups) had significantly lower oxytocin concentrations compared to healthy control participants. Hypopituitary patients also performed significantly worse on both the reading the mind in the eyes task and the facial expression recognition task compared to healthy control participants. Regression analyses further revealed that central diabetes insipidus patients’ oxytocin concentrations significantly predicted their performance on easy items of the reading the mind in the eyes task. Conclusions Hypopituitarism may therefore be associated with reduced oxytocin concentrations and impaired empathic ability. While further studies are needed to replicate these findings, our data suggest that oxytocin replacement may offer a therapeutic approach to improve psychological well-being in patients with hypopituitarism

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

In 2008 we published the first set of guidelines for standardizing research in autophagy. Since then, research on this topic has continued to accelerate, and many new scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Accordingly, it is important to update these guidelines for monitoring autophagy in different organisms. Various reviews have described the range of assays that have been used for this purpose. Nevertheless, there continues to be confusion regarding acceptable methods to measure autophagy, especially in multicellular eukaryotes. For example, a key point that needs to be emphasized is that there is a difference between measurements that monitor the numbers or volume of autophagic elements (e.g., autophagosomes or autolysosomes) at any stage of the autophagic process versus those that measure fl ux through the autophagy pathway (i.e., the complete process including the amount and rate of cargo sequestered and degraded). In particular, a block in macroautophagy that results in autophagosome accumulation must be differentiated from stimuli that increase autophagic activity, defi ned as increased autophagy induction coupled with increased delivery to, and degradation within, lysosomes (inmost higher eukaryotes and some protists such as Dictyostelium ) or the vacuole (in plants and fungi). In other words, it is especially important that investigators new to the fi eld understand that the appearance of more autophagosomes does not necessarily equate with more autophagy. In fact, in many cases, autophagosomes accumulate because of a block in trafficking to lysosomes without a concomitant change in autophagosome biogenesis, whereas an increase in autolysosomes may reflect a reduction in degradative activity. It is worth emphasizing here that lysosomal digestion is a stage of autophagy and evaluating its competence is a crucial part of the evaluation of autophagic flux, or complete autophagy. Here, we present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes. These guidelines are not meant to be a formulaic set of rules, because the appropriate assays depend in part on the question being asked and the system being used. In addition, we emphasize that no individual assay is guaranteed to be the most appropriate one in every situation, and we strongly recommend the use of multiple assays to monitor autophagy. Along these lines, because of the potential for pleiotropic effects due to blocking autophagy through genetic manipulation it is imperative to delete or knock down more than one autophagy-related gene. In addition, some individual Atg proteins, or groups of proteins, are involved in other cellular pathways so not all Atg proteins can be used as a specific marker for an autophagic process. In these guidelines, we consider these various methods of assessing autophagy and what information can, or cannot, be obtained from them. Finally, by discussing the merits and limits of particular autophagy assays, we hope to encourage technical innovation in the field

The Prüm Implementation, Evaluation and Strengthening (P.I.E.S.) of Forensic DNA Data Exchange. Northumbria University Final Report

This document is the final project outcome report of a 3 year E.C. funded research project with multiple european partners detailing the Northumbria University findings. The report details the examination of criminal offending across England for a 3 year period (2011 - 2013) by inter-EU migrants and the development of an intuitive and transferable analytical model of such offending. Analysis details (a) spatial patterns of offending at a meso scale (b)age-crime profiles of offenders by gender (c) types of crime committed before moving on to examine data availability across EU member states and the analytical models transferability. Spatial analsyis of inter-EU migrant offending is conducted from a wider EU perspective providing EU wide migrant offending context across Member States